- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Glenmark Pharmaceuticals Ltd Future - Aug 26
Glenmark Pharmaceuticals Ltd Future stock price live, this page displays NSE GLENc1:NS stock exchange data. View the GLENc1:NS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Glenmark Pharmaceuticals Ltd Future real time stock price chart below.
What Is the Glenmark Pharmaceuticals Ltd Future Stock Price Today?
The Glenmark Pharmaceuticals Ltd Future stock price today is 2,317.00.
What Is the Stock Symbol for Glenmark Pharmaceuticals Ltd Future?
The stock symbol for Glenmark Pharmaceuticals Ltd Future is "GLENc1:NS."
What Stock Exchange Does Glenmark Pharmaceuticals Ltd Future Trade On?
Glenmark Pharmaceuticals Ltd Future is listed and trades on the NSE stock exchange.
Is Glenmark Pharmaceuticals Ltd Future a Good Stock to Buy?
Determining whether Glenmark Pharmaceuticals Ltd Future—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLENc1:NS quote. (ISIN: )
What Is the Glenmark Pharmaceuticals Ltd Future Stock Price Today?
The Glenmark Pharmaceuticals Ltd Future stock price today is 2,317.00.
What Is the Stock Symbol for Glenmark Pharmaceuticals Ltd Future?
The stock symbol for Glenmark Pharmaceuticals Ltd Future is "GLENc1:NS."
What Stock Exchange Does Glenmark Pharmaceuticals Ltd Future Trade On?
Glenmark Pharmaceuticals Ltd Future is listed and trades on the NSE stock exchange.
Is Glenmark Pharmaceuticals Ltd Future a Good Stock to Buy?
Determining whether Glenmark Pharmaceuticals Ltd Future—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLENc1:NS quote. (ISIN: )
2,317.00
-10.20(-0.44%)
Closed·
Day's Range
2,309.00
2,343.00
52 wk Range
1,792.00
2,488.00
Day's Range
2,309.002,343.00
52 wk Range
1,792.002,488.00
- Bid/Ask
- 2,317.00 / 2,317.30
- Prev. Close
- 2,327.2
- Open
- 2,334.7
- Day's Range
- 2,309-2,343
- 52 wk Range
- 1,792-2,488
- Bid/Ask
- 2,317.00 / 2,317.30
- Prev. Close
- 2,327.2
- Open
- 2,334.7
- Day's Range
- 2,309-2,343
- 52 wk Range
- 1,792-2,488
- Volume
- 698,625
- 1-Year Change
- 13.2786%
- Settlement Day
- 2026/08/25
- Settlement Type
- Cash
- Month
- Aug 26
- Last Rollover Day
- 2026/07/28
- Contract Size
- 700 shares
- Tick Size
- 0.05
- Tick Value
- 35
- Base Symbol
- -
- Point Value
- 1=₹700
- Months
- FGHJKMNQUVXZ
- Bid/Ask
- 2,317.00 / 2,317.30
- Prev. Close
- 2,327.2
- Open
- 2,334.7
- Day's Range
- 2,309-2,343
- 52 wk Range
- 1,792-2,488
- Volume
- 698,625
- 1-Year Change
- 13.2786%
- Settlement Day
- 2026/08/25
- Settlement Type
- Cash
- Month
- Aug 26
- Last Rollover Day
- 2026/07/28
- Contract Size
- 700 shares
- Tick Size
- 0.05
- Tick Value
- 35
- Base Symbol
- -
- Point Value
- 1=₹700
- Months
- FGHJKMNQUVXZ
Type:Equity
Underlying:Glenmark Pharma
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
How do you feel today about GLENc1:NS?
Vote to see community's results!
or
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally. The company provides branded, OTC, and generic formulations in the therapeutic areas of dermatology, respiratory, oncology, immunology, pain management, hypertension, central nervous system, cardiology, diabetes, contraceptives, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injectables and biologics, oral solids, liquids, topical products, and respiratory-metered dose inhaler, dry powder inhaler, and nasal sprays. Its product pipeline includes ISB 2001, a CD38 x BCMA x CD3 TREAT trispecific T cell engager, which is in Phase 1 clinical trial for indication of relapsed/refractory multiple myeloma; ISB 2301, a NK cell engager that is in preclinical trial for solid tumors; and GRC 65327, a Cbl-b inhibitor small molecule for solid tumors. The company’s pipeline also comprises ISB 880, an IL-1RAP antagonist monoclonal antibody, which is in Phase 1 clinical trial for the treatment of hidradenitis suppurativa; and ISB 830-X8, a telazorlimab OX40 antagonist antibody that is in Phase 2 clinical trial for the treatment of atopic dermatitis. In addition, the company offers Ryaltris nasal spray for the treatment of seasonal allergic rhinitis. The company was incorporated in 1977 and is based in Mumbai, India.
FAQ
What Is the Glenmark Pharmaceuticals (GLENc1:NS) Stock Price Today?
The Glenmark Pharmaceuticals stock price today is 2,317.00 INR.
What Stock Exchange Does Glenmark Pharmaceuticals Trade On?
Glenmark Pharmaceuticals is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Glenmark Pharmaceuticals?
The stock symbol for Glenmark Pharmaceuticals is "GLENc1:NS."
What Is the Glenmark Pharmaceuticals Market Cap?
As of today, Glenmark Pharmaceuticals market cap is 654.71B INR.
From a Technical Analysis Perspective, Is GLENc1:NS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Glenmark Pharmaceuticals Stock Split?
Glenmark Pharmaceuticals has split 0 times.
How Many Employees Does Glenmark Pharmaceuticals Have?
Glenmark Pharmaceuticals has 15800 employees.
What is the current trading status of Glenmark Pharmaceuticals (GLENc1:NS)?
As of Aug 16, 2026, Glenmark Pharmaceuticals (GLENc1:NS) is trading at a price of 2,317.00 INR, with a previous close of 2,327.20 INR. The stock has fluctuated within a day range of 2,309.00 INR to 2,343.00 INR, while its 52-week range spans from 1,792.00 INR to 2,488.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.